Randomized, Controlled Study to Compare the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment Given Sequentially Following Cisplatin/Gemcitabine Versus Cisplatin/Gemcitabine in Patients With IntraHepatic Cholangiocarcinoma
Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Melphalan (Primary)
- Indications Cholangiocarcinoma
- Focus Registrational; Therapeutic Use
- Sponsors Delcath Systems
- 25 Jul 2017 Planned initiation date changed from 1 Sep 2017 to 1 Dec 2017.
- 09 May 2017 According to a Delcath Systems media release, this trial is planned to initiate in the Fall of 2017.
- 03 Apr 2017 New trial record